drugset / Trial / NCT02182076
Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study to assess pharmacokinetics and the extend of absorption of a single dose of BIBF 1120 soft gelatine capsule with food effect (BA) in healthy subjects respectively.
Timeline
- Start
- 2005-10
- Primary completion
- 2005-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nintedanib | Small molecule | 150 mg | — |
Indications
No indication recorded.